We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Consumer Discretionary 6.04%
3 Financials 5.89%
4 Industrials 4.61%
5 Healthcare 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCN
7076
DELISTED
Neovasc Inc.
NVCN
$20K ﹤0.01%
+1
New +$37.9K
AMPE
7077
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$20K ﹤0.01%
84
-22
-21% -$5.91K
ATHX
7078
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$20K ﹤0.01%
+464
New +$14.8K
WMGIZ
7079
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$20K ﹤0.01%
+12,377
New +$18.8K
MSLI
7080
DELISTED
Merus Labs International Inc.
MSLI
$20K ﹤0.01%
21,826
-14,729
-40% -$12.7K
OHGI
7081
DELISTED
One Horizon Group, Inc.
OHGI
$20K ﹤0.01%
11,757
+1,040
+10% +$1.82K
FENX
7082
DELISTED
Fenix Parts, Inc.
FENX
$20K ﹤0.01%
+12,659
New +$27.9K
GCVRZ
7083
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$20K ﹤0.01%
44,800
-10,927
-20% -$4.8K
COHN icon
7084
Cohen & Co
COHN
$38.8M
$19K ﹤0.01%
+1,673
New +$20.9K
ELTK icon
7085
Eltek
ELTK
$57.9M
$19K ﹤0.01%
5,524
+926
+20% +$3.75K
NEON icon
7086
Neonode
NEON
$15.7M
$19K ﹤0.01%
+1,205
New +$19.9K
RKDA icon
7087
Arcadia Biosciences
RKDA
$1.36M
$19K ﹤0.01%
+35
New +$25.1K
TENX icon
7088
Tenax Therapeutics
TENX
$68.9M
$19K ﹤0.01%
+1
New +$36.3K
OPGN
7089
DELISTED
OpGen, Inc
OPGN
0
NEPT
7090
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$19K ﹤0.01%
14
+4
+40% +$5.9K
AHPI
7091
DELISTED
Allied Healthcare Products
AHPI
$19K ﹤0.01%
+10,084
New +$20.7K
AMPE
7092
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$19K ﹤0.01%
+78
New +$21K
AXU
7093
PUT
DELISTED
Alexco Resource Corp
AXU
$19K ﹤0.01%
12,400
-1,000
-7% -$1.71K
SMTX
7094
DELISTED
SMTC Corporation
SMTX
$19K ﹤0.01%
15,184
+1,500
+11% +$2.08K
ROYT
7095
PUT
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$19K ﹤0.01%
+10,000
New +$15.1K
ARDM
7096
DELISTED
Aradigm Corp Common Stock
ARDM
$19K ﹤0.01%
+11,972
New +$22.2K
SPI
7097
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$19K ﹤0.01%
162
-31
-16% -$4.25K
UNIS
7098
CALL
DELISTED
Unilife Corporation
UNIS
$19K ﹤0.01%
+11,000
New +$23.1K
DRRX
7099
DELISTED
DURECT Corp
DRRX
$18K ﹤0.01%
1,704
-1,870
-52% -$20K
GEVO icon
7100
CALL
Gevo
GEVO
$418M
$18K ﹤0.01%
805
+779
+2,996% +$33K

Similar funds

Ken Griffin's Q1 2017 Portfolio in Review

As of Q1 2017, Ken Griffin held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ken Griffin's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Ken Griffin added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Ken Griffin's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Ken Griffin fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Ken Griffin's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Ken Griffin opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.